Pharmacological inhibition with the ataxia telangiectasia and Rad3-relevant protein serine/threonine kinase (ATR; often known as FRAP-associated protein (FRP1)) has emerged as a promising technique for most cancers remedy that exploits artificial lethal interactions with proteins involved with DNA harm maintenance, overcomes resistance to other therapies and enhances antitumour immuni... https://williami555vgq7.csublogs.com/profile